Status:
UNKNOWN
Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program
Lead Sponsor:
Biocerna LLC
Conditions:
Subjects Possibly Exposed to COVID-19
Eligibility:
All Genders
Brief Summary
We are trying to see whether a self-collected saliva swab in the home setting is as good as or better than a study clinician-collected anterior nose swab in evaluating whether you are positive for COV...
Detailed Description
In some research studies, saliva has been shown to be as good as or even better than an anterior nares or nasopharyngeal specimen in detecting SARS-CoV-2; we are interested in making sure that is the ...
Eligibility Criteria
Inclusion
- Patients will qualify because they live in a location which is reporting an increased number of COVID-19 positive cases. Incidence of Influenza A/Influenza B is also useful to track to find out whether social distancing and/or wearing masks decreases the number of Influenza A/Influenza B cases during the winter months.
- \-
Exclusion
- \-
Key Trial Info
Start Date :
November 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04681950
Start Date
November 24 2020
End Date
December 31 2020
Last Update
December 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biocerna LLC
Fulton, Maryland, United States, 20759